Coincidentally, we observed that NSCLC bone metastasis patients with the AC/AA genotype of CTNNB1: rs1880481 have a longer PFS, which further indicates CTNNB1: rs1880481 may be a protective prognostic biomarker. Here, CTNNB1 is linked to metastasis.